| Product Code: ETC7646932 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a declining compound annual growth rate (CAGR) from 2020 to 2024, the import shipments of bronchodilators to Israel continued to be sourced from a diverse range of countries. Switzerland, UK, Belgium, USA, and Germany emerged as the top exporting countries in 2024. With a low Herfindahl-Hirschman Index (HHI) indicating minimal market concentration, the market remains competitive. A slight negative growth rate in 2024 (-0.41%) suggests stability in the market for bronchodilators, with potential for further diversification in the future.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Bronchodilators Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Bronchodilators Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Bronchodilators Market - Industry Life Cycle |
3.4 Israel Bronchodilators Market - Porter's Five Forces |
3.5 Israel Bronchodilators Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Israel Bronchodilators Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Israel Bronchodilators Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
4 Israel Bronchodilators Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in Israel |
4.2.2 Growing awareness about bronchodilator therapies |
4.2.3 Technological advancements in bronchodilator medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals |
4.3.2 High cost of bronchodilator medications |
4.3.3 Competition from alternative treatment options |
5 Israel Bronchodilators Market Trends |
6 Israel Bronchodilators Market, By Types |
6.1 Israel Bronchodilators Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Bronchodilators Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Israel Bronchodilators Market Revenues & Volume, By Asthma, 2021- 2031F |
6.1.4 Israel Bronchodilators Market Revenues & Volume, By Chronic obstructive pulmonary disease (COPD), 2021- 2031F |
6.2 Israel Bronchodilators Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Bronchodilators Market Revenues & Volume, By Sympathomimetics, 2021- 2031F |
6.2.3 Israel Bronchodilators Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.2.4 Israel Bronchodilators Market Revenues & Volume, By Phosphodiesterase Inhibitor, 2021- 2031F |
6.2.5 Israel Bronchodilators Market Revenues & Volume, By Combination Drugs, 2021- 2031F |
6.3 Israel Bronchodilators Market, By Route Of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Bronchodilators Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Bronchodilators Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.4 Israel Bronchodilators Market Revenues & Volume, By Inhaler, 2021- 2031F |
7 Israel Bronchodilators Market Import-Export Trade Statistics |
7.1 Israel Bronchodilators Market Export to Major Countries |
7.2 Israel Bronchodilators Market Imports from Major Countries |
8 Israel Bronchodilators Market Key Performance Indicators |
8.1 Number of prescriptions for bronchodilator medications |
8.2 Patient adherence rate to bronchodilator therapies |
8.3 Rate of adoption of new bronchodilator products |
8.4 Average length of hospital stay for respiratory-related conditions |
8.5 Number of respiratory disease cases diagnosed annually |
9 Israel Bronchodilators Market - Opportunity Assessment |
9.1 Israel Bronchodilators Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Israel Bronchodilators Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Israel Bronchodilators Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
10 Israel Bronchodilators Market - Competitive Landscape |
10.1 Israel Bronchodilators Market Revenue Share, By Companies, 2024 |
10.2 Israel Bronchodilators Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here